
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
Vera Francisco, María‐Jesús Sanz, José T. Real, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 50
Vera Francisco, María‐Jesús Sanz, José T. Real, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
The Role of Adipokines in Inflammatory Mechanisms of Obesity
Tatiana V. Kirichenko, Yuliya V. Markina, Anastasia I. Bogatyreva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14982-14982
Open Access | Times Cited: 115
Tatiana V. Kirichenko, Yuliya V. Markina, Anastasia I. Bogatyreva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14982-14982
Open Access | Times Cited: 115
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1524-1541
Open Access | Times Cited: 70
Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1524-1541
Open Access | Times Cited: 70
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
Fani‐Niki Varra, Michail Varras, Viktoria‐Konstantina Varra, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 29
Fani‐Niki Varra, Michail Varras, Viktoria‐Konstantina Varra, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 29
Neuregulin 4 as a novel adipokine in energy metabolism
Yuanbin Liu, Mingkai Chen
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 23
Yuanbin Liu, Mingkai Chen
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 23
Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
Adina Chiş, Paul Aimé Noubissi, Oana Lelia Pop, et al.
Plants (2023) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 21
Adina Chiş, Paul Aimé Noubissi, Oana Lelia Pop, et al.
Plants (2023) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 21
Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
Xinyu Li, Maozhang He, Xinrui Yi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26991-e26991
Open Access | Times Cited: 12
Xinyu Li, Maozhang He, Xinrui Yi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26991-e26991
Open Access | Times Cited: 12
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype
Heng Yuan, Xuangao Wu, Xichun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2183-2183
Open Access | Times Cited: 10
Heng Yuan, Xuangao Wu, Xichun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2183-2183
Open Access | Times Cited: 10
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 10
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 10
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
Patrice Marqués, Vera Francisco, Laura Martínez‐Arenas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2313-2313
Open Access | Times Cited: 15
Patrice Marqués, Vera Francisco, Laura Martínez‐Arenas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2313-2313
Open Access | Times Cited: 15
The role of adiponectin for immune cell function in metabolic diseases
Mingyue Gao, Dawei Cui, Jue Xie
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2427-2438
Closed Access | Times Cited: 14
Mingyue Gao, Dawei Cui, Jue Xie
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2427-2438
Closed Access | Times Cited: 14
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, M. Castorina, et al.
Life (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 4
Salvatore Pezzino, Tonia Luca, M. Castorina, et al.
Life (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 4
Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, et al.
Hepatology Communications (2023) Vol. 7, Iss. 6
Open Access | Times Cited: 10
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, et al.
Hepatology Communications (2023) Vol. 7, Iss. 6
Open Access | Times Cited: 10
The Pan-liver Network Theory
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 10
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 10
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Haoran Jiang, Linquan Zang
Current Pharmaceutical Design (2024) Vol. 30, Iss. 2, pp. 100-114
Closed Access | Times Cited: 3
Haoran Jiang, Linquan Zang
Current Pharmaceutical Design (2024) Vol. 30, Iss. 2, pp. 100-114
Closed Access | Times Cited: 3
Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients
Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, et al.
Cureus (2024)
Open Access | Times Cited: 3
Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, et al.
Cureus (2024)
Open Access | Times Cited: 3
Effect of High Energy Low Protein Diet on Lipid Metabolism and Inflammation in the Liver and Abdominal Adipose Tissue of Laying Hens
Xiaxia Du, Yinuo Wang, Felix Kwame Amevor, et al.
Animals (2024) Vol. 14, Iss. 8, pp. 1199-1199
Open Access | Times Cited: 3
Xiaxia Du, Yinuo Wang, Felix Kwame Amevor, et al.
Animals (2024) Vol. 14, Iss. 8, pp. 1199-1199
Open Access | Times Cited: 3
A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination
Dan Lv, Zepu Wang, Cuiqiao Meng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Dan Lv, Zepu Wang, Cuiqiao Meng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
Leila Mobasheri, Mitra Ahadi, Ali Beheshti Namdar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115502-115502
Open Access | Times Cited: 9
Leila Mobasheri, Mitra Ahadi, Ali Beheshti Namdar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115502-115502
Open Access | Times Cited: 9
Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks
Thomas M. Barber, Stefan Kabisch, A. Pfeiffer, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 757-757
Open Access | Times Cited: 8
Thomas M. Barber, Stefan Kabisch, A. Pfeiffer, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 757-757
Open Access | Times Cited: 8
Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
B Zhang, Jinger Lu, Yuhua Jiang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 8
B Zhang, Jinger Lu, Yuhua Jiang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 8
Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease
Bitasta Mandal, Rakesh Das, Sandip Mondal
Annales Pharmaceutiques Françaises (2024) Vol. 82, Iss. 3, pp. 373-391
Closed Access | Times Cited: 2
Bitasta Mandal, Rakesh Das, Sandip Mondal
Annales Pharmaceutiques Françaises (2024) Vol. 82, Iss. 3, pp. 373-391
Closed Access | Times Cited: 2
Visceral fat area is more strongly associated with arterial stiffness than abdominal subcutaneous fat area in Chinese patients with type 2 diabetes
Jing Mao, Shenglian Gan, Shijun Gong, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Jing Mao, Shenglian Gan, Shijun Gong, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation
Henghui Xu, Sheng-xin Hao, Heyang Sun, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 10, pp. 2107-2118
Closed Access | Times Cited: 2
Henghui Xu, Sheng-xin Hao, Heyang Sun, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 10, pp. 2107-2118
Closed Access | Times Cited: 2
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment
Ana Luz Tobaruela-Resola, Fermı́n I. Milagro, Mariana Elorz, et al.
Journal of Physiology and Biochemistry (2024)
Open Access | Times Cited: 2
Ana Luz Tobaruela-Resola, Fermı́n I. Milagro, Mariana Elorz, et al.
Journal of Physiology and Biochemistry (2024)
Open Access | Times Cited: 2
Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
Amir Hossein Behnoush, Parnian Shobeiri, Pegah Bahiraie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Amir Hossein Behnoush, Parnian Shobeiri, Pegah Bahiraie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6